V A Znamensky, K V Chelnyntsev, M A Lisovsky, E A Lyasnikova, M Yu Sitnikova, P A Fedotov
{"title":"[Effectiveness Analysis of The I NEED HELP Scale For Prognostic Evaluation of Heart Transplant Waiting List Patients].","authors":"V A Znamensky, K V Chelnyntsev, M A Lisovsky, E A Lyasnikova, M Yu Sitnikova, P A Fedotov","doi":"10.18087/cardio.2025.2.n2830","DOIUrl":null,"url":null,"abstract":"<p><p>Aim To evaluate the efficacy of the I NEED HELP scale in determining the six-month prognosis for patients on the heart transplant waiting list (HTWL) of the Almazov National Medical Research Center of the Russian Ministry of Health.Material and methods This retrospective study included 42 patients from the HTWL. The patients' survival for more than 6 months was assessed. The composite end point (CEP) of adverse outcome was all-cause death, heart transplantation (HT) due to the increased urgency of surgical intervention according to UNOS within 6 months after the inclusion in the HTWL. Patients were evaluated using the I NEED HELP scale. Statistical analysis was performed by nonparametric methods.Results The median I NEED HELP score was 4 [from 1 to 7]. The increase in score was positively correlated with the incidence of adverse outcomes (r=0.5; p=0.0007). The group of patients with an unfavorable outcome had a median score higher by one than for the survivors (score 5 vs. 4, respectively; p=0.001). The greatest effect on the prognosis was exerted by low systolic blood pressure (SBP) (p=0.003); the failure to increase or the necessity to decrease the doses of disease-modifying drugs (p=0.039); and target organ dysfunction (p=0.039). The sensitivity and specificity of the scale at a score 5 or higher were 100% and 84%, respectively.Conclusion This pilot study demonstrated the efficacy of the I NEED HELP scale in a patient population from a specialized center HTWL with high sensitivity and specificity at the determined threshold score 5 for an unfavorable outcome. It is appropriate to continue the study with an expanded sample and validation of the scale on patient cohorts from hospitals of various healthcare system levels.</p>","PeriodicalId":54750,"journal":{"name":"Kardiologiya","volume":"65 2","pages":"64-68"},"PeriodicalIF":0.5000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kardiologiya","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18087/cardio.2025.2.n2830","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Aim To evaluate the efficacy of the I NEED HELP scale in determining the six-month prognosis for patients on the heart transplant waiting list (HTWL) of the Almazov National Medical Research Center of the Russian Ministry of Health.Material and methods This retrospective study included 42 patients from the HTWL. The patients' survival for more than 6 months was assessed. The composite end point (CEP) of adverse outcome was all-cause death, heart transplantation (HT) due to the increased urgency of surgical intervention according to UNOS within 6 months after the inclusion in the HTWL. Patients were evaluated using the I NEED HELP scale. Statistical analysis was performed by nonparametric methods.Results The median I NEED HELP score was 4 [from 1 to 7]. The increase in score was positively correlated with the incidence of adverse outcomes (r=0.5; p=0.0007). The group of patients with an unfavorable outcome had a median score higher by one than for the survivors (score 5 vs. 4, respectively; p=0.001). The greatest effect on the prognosis was exerted by low systolic blood pressure (SBP) (p=0.003); the failure to increase or the necessity to decrease the doses of disease-modifying drugs (p=0.039); and target organ dysfunction (p=0.039). The sensitivity and specificity of the scale at a score 5 or higher were 100% and 84%, respectively.Conclusion This pilot study demonstrated the efficacy of the I NEED HELP scale in a patient population from a specialized center HTWL with high sensitivity and specificity at the determined threshold score 5 for an unfavorable outcome. It is appropriate to continue the study with an expanded sample and validation of the scale on patient cohorts from hospitals of various healthcare system levels.
目的评价I NEED HELP量表对俄罗斯卫生部Almazov国家医学研究中心心脏移植等待名单(HTWL)患者6个月预后的影响。材料与方法本回顾性研究纳入42例HTWL患者。评估患者6个月以上的生存期。不良结局的复合终点(CEP)为全因死亡,心脏移植(HT),根据UNOS,在纳入HTWL后6个月内,由于手术干预的紧迫性增加。使用I NEED HELP量表对患者进行评估。采用非参数方法进行统计分析。结果I NEED HELP评分中位数为4分[从1到7分]。评分的增加与不良结局的发生率呈正相关(r=0.5;p = 0.0007)。结果不良的患者组的中位评分比幸存者组高1分(分别为5分对4分;p = 0.001)。低收缩压对预后影响最大(p=0.003);不能增加或必须减少减轻疾病药物的剂量(p=0.039);靶器官功能障碍(p=0.039)。量表在5分及以上的敏感性为100%,特异性为84%。结论:本初步研究证明了I NEED HELP量表在来自专业中心HTWL的患者群体中具有高灵敏度和特异性,在确定的不利结果阈值5分时具有很高的疗效。适当的做法是继续扩大样本,并对来自不同医疗保健系统级别医院的患者队列进行规模验证。
期刊介绍:
“Kardiologiya” (Cardiology) is a monthly scientific, peer-reviewed journal committed to both basic cardiovascular medicine and practical aspects of cardiology.
As the leader in its field, “Kardiologiya” provides original coverage of recent progress in cardiovascular medicine. We publish state-of-the-art articles integrating clinical and research activities in the fields of basic cardiovascular science and clinical cardiology, with a focus on emerging issues in cardiovascular disease. Our target audience spans a diversity of health care professionals and medical researchers working in cardiovascular medicine and related fields.
The principal language of the Journal is Russian, an additional language – English (title, authors’ information, abstract, keywords).
“Kardiologiya” is a peer-reviewed scientific journal. All articles are reviewed by scientists, who gained high international prestige in cardiovascular science and clinical cardiology. The Journal is currently cited and indexed in major Abstracting & Indexing databases: Web of Science, Medline and Scopus.
The Journal''s primary objectives
Contribute to raising the professional level of medical researchers, physicians and academic teachers.
Present the results of current research and clinical observations, explore the effectiveness of drug and non-drug treatments of heart disease, inform about new diagnostic techniques; discuss current trends and new advancements in clinical cardiology, contribute to continuing medical education, inform readers about results of Russian and international scientific forums;
Further improve the general quality of reviewing and editing of manuscripts submitted for publication;
Provide the widest possible dissemination of the published articles, among the global scientific community;
Extend distribution and indexing of scientific publications in major Abstracting & Indexing databases.